Biodesix won the award for “Innovative Company of the Year” last night at the 2016 IQ Awards and Innovation Summit presented by BizWest Media. The other finalists in the category were Fort Collins-based Madwire and n.io of Broomfield.
“We are really in the business of helping cancer patients to determine the most effective treatment for their disease – through a simple blood draw.” said Bobbi Coffin, vice president of marketing for Biodesix, as she accepted the award. “By combining large sets of patient data with innovative machine learning – something we call the Diagnostic Cortex - Biodesix is able to discover new blood-based cancer diagnostics that help physicians determine the best treatments for patients with advanced cancer.
The IQ Awards honors the “Innovation Quotient” among companies and organizations based in Boulder, Broomfield, Larimer and Weld counties, as well as local divisions of national and international companies that have been instrumental in developing the most innovative products and services.
Biodesix® is a molecular diagnostics company advancing the development of innovative blood tests in oncology to enable precision medicine. Biodesix discovers, develops and commercializes multivariate protein and genomic diagnostic blood tests, including the GeneStrat® and VeriStrat® tests, that deliver results within 72 hours. The company is changing the standard of care by providing physicians with diagnostic tests for better therapeutic guidance, more accurate prognosis and enhanced disease monitoring to improve patient outcomes. At the forefront of precision medicine, Biodesix is developing new blood tests to identify patients who may benefit from immunotherapies. In addition to developing novel diagnostics independently, the company partners with biotechnology and pharmaceutical companies to develop companion diagnostics for use with therapeutic agents.